{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies containing amyloid fibrils of α-synuclein (αSyn). The study suggests that cellular toxicity is caused by a soluble oligomeric species, a precursor to the amyloid form, which correlates with disease-associated mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of PD as involving the formation of cytotoxic oligomeric species of αSyn, which is relevant to the functional assays described for the variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses an in vitro system with 20S proteasome and liposomes to evaluate αSyn degradation, oligomer formation, and amyloidogenesis, aiming to mimic cellular conditions and assess the formation of cytotoxic oligomers.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (in vitro biochemical assays assessing oligomer formation and protein degradation) effectively models the disease mechanism of PD by focusing on the formation of cytotoxic oligomers, a key aspect of pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type αSyn as a control and performs experiments in triplicate for fibrillization and oligomerization assays (e.g., 'The aggregation reaction was performed in triplicate in microtiter plates'; 'Data from three independent experiments were quantitated').",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type αSyn) and replicates (triplicate experiments) are explicitly mentioned, meeting the criteria for sufficient experimental design.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study evaluates multiple disease-associated mutations (A53T, A30P, E46K) alongside wild-type αSyn, but does not specify additional known pathogenic or benign variants as controls beyond these.",
          "judgment": "No",
          "reasoning": "While disease-associated mutations are tested, there is no mention of additional known pathogenic or benign variants classified independently of PS3/BS3 as controls, failing to meet the criteria for variant controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A53T is rated as PS3_supporting due to the clear definition of the disease mechanism and the applicability of the in vitro assay system in modeling cytotoxic oligomer formation. However, the lack of additional variant controls limits the strength to supporting, despite the presence of basic controls and replicates."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies containing amyloid fibrils of α-synuclein (αSyn). The study suggests that cellular toxicity is caused by a soluble oligomeric species, a precursor to the amyloid form, which correlates with disease-associated mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of PD as involving the formation of cytotoxic oligomeric species of αSyn, which is relevant to the functional assays described for the variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses an in vitro system with 20S proteasome and liposomes to evaluate αSyn degradation, oligomer formation, and amyloidogenesis, aiming to mimic cellular conditions and assess the formation of cytotoxic oligomers.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (in vitro biochemical assays assessing oligomer formation and protein degradation) effectively models the disease mechanism of PD by focusing on the formation of cytotoxic oligomers, a key aspect of pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type αSyn as a control and performs experiments in triplicate for fibrillization and oligomerization assays (e.g., 'The aggregation reaction was performed in triplicate in microtiter plates'; 'Data from three independent experiments were quantitated').",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type αSyn) and replicates (triplicate experiments) are explicitly mentioned, meeting the criteria for sufficient experimental design.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study evaluates multiple disease-associated mutations (A53T, A30P, E46K) alongside wild-type αSyn, but does not specify additional known pathogenic or benign variants as controls beyond these.",
          "judgment": "No",
          "reasoning": "While disease-associated mutations are tested, there is no mention of additional known pathogenic or benign variants classified independently of PS3/BS3 as controls, failing to meet the criteria for variant controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA A30P is rated as PS3_supporting due to the clear definition of the disease mechanism and the applicability of the in vitro assay system in modeling cytotoxic oligomer formation. However, the lack of additional variant controls limits the strength to supporting, despite the presence of basic controls and replicates."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "SNCA E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease (PD) is characterized by the selective loss of dopaminergic neurons and the presence of Lewy bodies containing amyloid fibrils of α-synuclein (αSyn). The study suggests that cellular toxicity is caused by a soluble oligomeric species, a precursor to the amyloid form, which correlates with disease-associated mutations.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism of PD as involving the formation of cytotoxic oligomeric species of αSyn, which is relevant to the functional assays described for the variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses an in vitro system with 20S proteasome and liposomes to evaluate αSyn degradation, oligomer formation, and amyloidogenesis, aiming to mimic cellular conditions and assess the formation of cytotoxic oligomers.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (in vitro biochemical assays assessing oligomer formation and protein degradation) effectively models the disease mechanism of PD by focusing on the formation of cytotoxic oligomers, a key aspect of pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type αSyn as a control and performs experiments in triplicate for fibrillization and oligomerization assays (e.g., 'The aggregation reaction was performed in triplicate in microtiter plates'; 'Data from three independent experiments were quantitated').",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type αSyn) and replicates (triplicate experiments) are explicitly mentioned, meeting the criteria for sufficient experimental design.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "The study evaluates multiple disease-associated mutations (A53T, A30P, E46K) alongside wild-type αSyn, but does not specify additional known pathogenic or benign variants as controls beyond these.",
          "judgment": "No",
          "reasoning": "While disease-associated mutations are tested, there is no mention of additional known pathogenic or benign variants classified independently of PS3/BS3 as controls, failing to meet the criteria for variant controls.",
          "next_step_or_outcome": "Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for SNCA E46K is rated as PS3_supporting due to the clear definition of the disease mechanism and the applicability of the in vitro assay system in modeling cytotoxic oligomer formation. However, the lack of additional variant controls limits the strength to supporting, despite the presence of basic controls and replicates."
    }
  ]
}